PresseMitteilungen CategoriesNewBiotechCategory / Pharmaceuticals & Biotech / Biotech Corbus Pharmaceuticals Reports 2014 Third Quarter Results and Business Update NORWOOD, MA: ... UPDATE - Avita Medical Provides NICE Guidance Recommendation Update NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ... Theravance Biopharma to Present at the Stifel Healthcare Conference on November 18th SOUTH SAN FRANCISCO, CA: ... ImmuCell Announces Financial Results for Third Quarter of 2014 PORTLAND, ME: Sales for Third Quarter and Nine Months Increase 43% and 21%, Respectively ... Atossa Genetics Announces Third Quarter 2014 Financial Results and Provides Company Update SEATTLE, WA: Conference Call to Be Held Today at 4:30 pm Eastern Time ... Avita Medical Provides NICE Guidance Recommendation Update NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ... ViroCyt Wins Colorado BioScience Association''s "Rising Star" Award BOULDER, CO: ... ONL Therapeutics Receives Phase II SBIR Grant From National Eye Institute for Development of Novel Retinal Disease Treatment ANN ARBOR, MI: Company Is Pioneering Photoreceptor Protection Technology to Preserve Vision ... Immunovaccine Receives Conditional Approval to Graduate to Toronto Stock Exchange (TSX) HALIFAX, NOVA SCOTIA: Shares to be Listed Under Symbol "IMV" on Canada's Senior Stock Exchange ... Horizon Pharma plc Announces Favorable Markman Ruling in RAYOS(R) (prednisone) Delayed-Release Tablets Patent Infringement Litigation DUBLIN, IRELAND: ... Horizon Pharma plc to Present at the Stifel 2014 Healthcare Conference DUBLIN, IRELAND: ... Coverage Initiation Report Focuses on Oramed Pharmaceuticals NEW YORK, NY: ... Global Biopharmaceutical Company UCB Expands Real Estate Services Relationship With JLL LONDON, UNITED KINGDOM: ... MYOS Corporation to Announce Third Quarter 2014 Financial Results and Host Conference Call on November 14, 2014 CEDAR KNOLLS, NJ: Conference Call and Webcast Scheduled for Friday, November 14, 2014 at 10:00 a.m. ET ... Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014 BEVERLY, MA: ... Titan Pharmaceuticals Appoints Two New Board Members SOUTH SAN FRANCISCO, CA: ... Threshold Pharmaceuticals Receives FDA Fast Track Designation for TH-302 for the Treatment of Previously Untreated Patients With Metastatic or Locally Advanced Unresectable Soft Tissue Sarcoma SOUTH SAN FRANCISCO, CA: ... ProMetic''s PBI-4050 Cleared to Commence Clinical Trials in Patients with Diabetic Kidney Disease LAVAL, QUEBEC: - Clinical Trial Application ("CTA") clearance received from Health Canada - Enrollment of first patients to begin this month ... Avita Medical Announces Receipt of $1.4 Million R&D Tax Incentive NORTHRIDGE, CA and CAMBRIDGE, UNITED KINGDOM: ... Alchemia Announces Departure of Chief Executive Officer BRISBANE, AUSTRALIA: ... Page 95 von 247: 1 « .. 94 95 96 97 98 99 100 101 102 103 .. » 247